Merit Medical Systems (MMSI) Gross Margin (2010 - 2026)

Merit Medical Systems has disclosed Gross Margin across 17 years of filings, most recently posting 48.39% for Q1 2026.

• Gross Margin for Q1 2026 came in at 48.39%, down 2.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 48.69% (up 89.0% YoY), and the FY2025 annual result was 48.7%, up 128.0% from the prior year.
• Gross Margin came in at 48.39% for Q1 2026 at Merit Medical Systems, down from 49.59% in the prior quarter.
• In the past five years, Gross Margin ranged from a high of 49.59% in Q4 2025 to a low of 43.9% in Q1 2022.
• The 5-year median for Gross Margin is 46.9% (2024), against an average of 46.99%.
• Across the five-year window, Gross Margin slumped 105 bps in 2022 and surged 260 bps in 2023, its largest moves.
• Merit Medical Systems' Gross Margin stood at 45.86% in 2022, then climbed by 1 bps to 46.39% in 2023, then climbed by 5 bps to 48.71% in 2024, then grew by 2 bps to 49.59% in 2025, then dropped by 2 bps to 48.39% in 2026.
• The last three Gross Margin figures came in at 48.39% (Q1 2026), 49.59% (Q4 2025), and 48.52% (Q3 2025), per Business Quant data.